Overview
Hereditary ataxia is a broad group of genetically determined neurological disorders characterized by progressive cerebellar dysfunction leading to impaired coordination and balance. This category encompasses a wide spectrum of conditions including the autosomal dominant spinocerebellar ataxias (SCAs), autosomal recessive ataxias such as Friedreich ataxia and ataxia-telangiectasia, X-linked ataxias, and mitochondrial ataxias. The primary body system affected is the central nervous system, particularly the cerebellum and its connections, though the spinal cord, peripheral nerves, brainstem, and other organ systems may also be involved depending on the specific subtype. Key clinical features shared across hereditary ataxias include progressive gait and limb ataxia (incoordination), dysarthria (slurred speech), oculomotor abnormalities (such as nystagmus and saccadic pursuit), and impaired balance. Depending on the specific genetic subtype, additional features may include peripheral neuropathy, pyramidal signs (spasticity, hyperreflexia), extrapyramidal features (dystonia, parkinsonism), cognitive impairment, seizures, cardiomyopathy, skeletal deformities, and visual or hearing loss. Age of onset varies widely, from early childhood to late adulthood, and the rate of progression differs substantially among subtypes. Currently, there is no curative treatment for most hereditary ataxias. Management is primarily supportive and symptomatic, including physical therapy, occupational therapy, speech therapy, and assistive devices to maintain mobility and independence. Specific pharmacological treatments exist for a few subtypes — for example, omaveloxolone (Skyclarys) has been approved for Friedreich ataxia. Genetic counseling is essential for affected individuals and their families. Research into gene therapy, antisense oligonucleotides, and other targeted molecular therapies is actively ongoing for several subtypes.
Variable
Can be inherited in different ways depending on the underlying gene
Variable
Can begin at different ages, from infancy through adulthood
FDA & Trial Timeline
1 eventSecond Affiliated Hospital, School of Medicine, Zhejiang University
Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
Treatments
No FDA-approved treatments are currently listed for Hereditary ataxia.
1 clinical trialare actively recruiting — trials can provide access to cutting-edge therapies.
View clinical trials →Rare Disease Specialist
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Hereditary ataxia.
Community
No community posts yet. Be the first to share your experience with Hereditary ataxia.
Start the conversation →Latest news about Hereditary ataxia
No recent news articles for Hereditary ataxia.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Hereditary ataxia
What is Hereditary ataxia?
Hereditary ataxia is a broad group of genetically determined neurological disorders characterized by progressive cerebellar dysfunction leading to impaired coordination and balance. This category encompasses a wide spectrum of conditions including the autosomal dominant spinocerebellar ataxias (SCAs), autosomal recessive ataxias such as Friedreich ataxia and ataxia-telangiectasia, X-linked ataxias, and mitochondrial ataxias. The primary body system affected is the central nervous system, particularly the cerebellum and its connections, though the spinal cord, peripheral nerves, brainstem, and
Are there clinical trials for Hereditary ataxia?
Yes — 1 recruiting clinical trial is currently listed for Hereditary ataxia on UniteRare. See the clinical trials section on this page for phase, sponsor, and site details sourced from ClinicalTrials.gov.
Which specialists treat Hereditary ataxia?
25 specialists and care centers treating Hereditary ataxia are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.